A Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Phase IIa Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs CT P27 (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Celltrion
- 30 Mar 2017 Status changed from to completed.
- 11 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Mar 2014 New trial record